WILEX
WILEX is a biopharmaceutical company developing drugs and diagnostic agents to detect and treat malignant tumors and cancers.
WILEX has raised €24M across 2 funding rounds from 1 investor, most recently a round in Mar 2010. Based in Munich, Germany; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€24M
€24,363,000
Funding rounds
2
Investors
1
distinct backers
Active since
1999-01
latest 2010-03
Funding by year
EUR raised per yearWILEX — funding by year — interactive chart.
Data table
| WILEX — funding by year | |
|---|---|
| 1998 | €0 |
| 2010 | €24M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2010-03-01 | Other | €24M | — | View deal → |
| 1999-01-01 | Other | €0 | Earlybird Venture Capital | View deal → |
Investors
1Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData